FDA DG Opening Statement
DOH Press Conference
November 16, 2017
I am pleased and honored to join our Secretary of Health, the Honorable Francisco T. Duque III in today’s press conference.
At the outset, I would like to say that Secretary Duque’s acceptance of the health portfolio was well-timed and was a blessing to the FDA. In more ways than one, Secretary Duque’s guidance to, as well as his confidence and trust in the processes and procedures of the FDA, proved to be very valuable as the reevaluation and recertification process came to the homestretch.
For this, I would like to publicly express my gratitude to Secretary Duque on behalf of the scientists and the technical teams of the FDA.
Thank you, Mr. Secretary.
For the FDA’s part, we are happy to have done our part in making sure that the government’s Reproductive Health Program gets back on track.
We are happy that President Duterte has given us his full support in the task of recertifying the contraceptive products covered by a resolution of the Supreme Court.
The President’s trust and confidence enabled us to adhere to the highest standards of scientific and technical testing which, in turn, assures the public that the contraceptives recertified by the FDA are safe and are non-abortifacient.
We thank the President for helping us get our job done and done well.
Thank you everyone.
The Food and Drug Administration (FDA) announced that the technical review and reevaluation process of 51 contraceptive products covered by a resolution issued by the Supreme Court has been completed.
The FDA in an advisory, said that the 51 contraceptive products the agency evaluated for months have passed the strict requirements of the technical review and reevaluation process.
Having met the requirements and passed the standards, the FDA is now preparing the recertification of these products.
The recertification will attest to the safety of the products and that these have been determined to be NON-ABORTIFACIENT.
The complete list has been posted in the FDA website and social media accounts.
The FDA also thanked the various sectors which helped the agency ensure that the recertification process is participative and transparent even as we adhered strictly to the methods of science in undertaking this task
DOH-FDA Healthcare Forum on Biotechnology
In line with the celebration of the 13th National Biotech Week, the Department of Health through the Food and Drug Administration will be conducting a Healthcare Forum on Biotechnology on 23 November 2017, 8:00 AM – 12:30 PM at the 4th Floor Conference Hall, National Meat Inspection Service, BAI Compound Visayas Ave, Vasra Diliman, Quezon City, 1128 Metro Manila.
Mark your calendars, stakeholders and consumers are invited.
Admission is free!